Latest Articles
Aberrant mRNA Splicing Fuels Endometriotic Cell Growth - Bioengineer.org
Aberrant mRNA Splicing Fuels Endometriotic Cell Growth Bioengineer.org
Published: May 29, 2026, 7:56 p.m.
mRNA Therapy Offers Hope for Uterine Factor Infertility - Technology Networks
mRNA Therapy Offers Hope for Uterine Factor Infertility Technology Networks
Published: May 28, 2026, 2:57 p.m.
Referee Explains Caitlin Clark's Flagrant Foul On Angel Reese In WNBA Opener Kacey Musgraves (mArYrezKmR) - Mshale
Referee Explains Caitlin Clark's Flagrant Foul On Angel Reese In WNBA Opener Kacey Musgraves (mArYrezKmR) Mshale
Published: May 26, 2026, 7:19 p.m.
Dostarlimab Plus Chemotherapy Demonstrates Sustained Disease Control in dMMR/MSI-H Advanced Endometrial Cancer - HMP Global Learning Network
Dostarlimab Plus Chemotherapy Demonstrates Sustained Disease Control in dMMR/MSI-H Advanced Endometrial Cancer HMP Global Learning Network
Published: May 26, 2026, 4:46 p.m.
P. D. Hinduja Hospital & MRC launched Multidisciplinary Endometriosis Clinic - IndiaMedToday
P. D. Hinduja Hospital & MRC launched Multidisciplinary Endometriosis Clinic IndiaMedToday
Published: May 24, 2026, 9:12 a.m.
Merck (MRK) Phase 3 TroFuse-005 Trial for Endometrial Cancer Meets Primary Endpoints - Yahoo Finance
Merck (MRK) Phase 3 TroFuse-005 Trial for Endometrial Cancer Meets Primary Endpoints Yahoo Finance
Published: May 23, 2026, 12:01 p.m.
Dostarlimab Combo Shows Durable Disease Control in dMMR/MSI-H Endometrial Cancer, Full Data Due at ASCO 2026 - OncLive
Dostarlimab Combo Shows Durable Disease Control in dMMR/MSI-H Endometrial Cancer, Full Data Due at ASCO 2026 OncLive
Published: May 22, 2026, 3:43 a.m.
How Investors Are Reacting To Merck (MRK) TroFuse ADC’s Breakthrough Endometrial Cancer Phase 3 Trial Results - Yahoo Finance
How Investors Are Reacting To Merck (MRK) TroFuse ADC’s Breakthrough Endometrial Cancer Phase 3 Trial Results Yahoo Finance
Published: May 20, 2026, 6:22 p.m.
How Sacituzumab Trial Success In Endometrial Cancer At Merck (MRK) Has Changed Its Investment Story - simplywall.st
How Sacituzumab Trial Success In Endometrial Cancer At Merck (MRK) Has Changed Its Investment Story simplywall.st
Published: May 20, 2026, 5:46 a.m.
Merck (MRK) Achieves Milestone in Endometrial Cancer Treatment T - GuruFocus
Merck (MRK) Achieves Milestone in Endometrial Cancer Treatment T GuruFocus
Published: May 18, 2026, 10:39 p.m.
Link copied to clipboard!